Skip Navigation
Skip to contents

Intest Res.  2016 Oct;14(4):322-332. 10.5217/ir.2016.14.4.322.

Surgical management of inflammatory bowel disease in China: a systematic review of two decades

Affiliations
  • 1Department of Gastroenterology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. chenminhu@vip.163.com maoren2023@163.com
  • 2Department of Colorectal Surgery, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • 3Department of Medicine and Therapeutics, Institute of Digestive Disease, State Key Laboratory of Digestive Diseases, Chinese University of Hong Kong, Hong Kong, China.
  • 4Department of General Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • 5IBD Service, Department of Gastroenterology, Sheba Medical Center & Sackler School of Medicine, Tel-Aviv University, Tel Hashomer, Israel.

Abstract

BACKGROUND/AIMS
The past decades have seen increasing incidence and prevalence of inflammatory bowel disease (IBD) in China. This article aimed to summarize the current status and characteristics of surgical management for IBD in China.
METHODS
We searched PubMed, Embase, and Chinese databases from January 1, 1990 to July 1, 2014 for all relevant studies on the surgical treatment IBD in China. Eligible studies with sufficient defined variables were further reviewed for primary and secondary outcome measures.
RESULTS
A total of 74 studies comprising 2,007 subjects with Crohn's disease (CD) and 1,085 subjects with ulcerative colitis (UC) were included. The percentage of CD patients misdiagnosed before surgery, including misdiagnosis as appendicitis or UC, was 50.8%±30.9% (578/1,268). The overall postoperative complication rate was 22.3%±13.0% (267/1,501). For studies of UC, the overall postoperative complication rate was 22.2%±27.9% (176/725). In large research centers (n>50 surgical cases), the rates of emergency operations for CD (P=0.032) and in-hospital mortalities resulting from both CD and UC were much lower than those in smaller research centers (n≤50 surgical cases) (P=0.026 and P <0.001, respectively). Regarding the changes in CD and UC surgery over time, postoperative complications (P=0.045 for CD; P=0.020 for UC) and postoperative in-hospital mortality (P=0.0002 for CD; P=0.0160 for UC) both significantly improved after the year 2010.
CONCLUSIONS
The surgical management of IBD in China has improved over time. However, the rates of misdiagnosis and postoperative complications over the past two decades have remained high. Large research centers were found to have relatively better capacity for surgical management than the smaller ones. Higher quality prospective studies are needed in China.

Keyword

Inflammatory bowel disease; General surgery; China; Systematic review

MeSH Terms

Appendicitis
Asian Continental Ancestry Group
China*
Colitis, Ulcerative
Crohn Disease
Diagnostic Errors
Emergencies
Hospital Mortality
Humans
Incidence
Inflammatory Bowel Diseases*
Outcome Assessment (Health Care)
Postoperative Complications
Prevalence
Prospective Studies
Full Text Links
  • IR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2026 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr